Home
Conditions
Recurrence

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies

Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Impact of Smoking Cessation on Sleep - 5

NCT00132821

Conditions: Behavior, Chemically-Induced Disorders, Disease Attributes, +14 more
Locations: SRI International Menlo Park, California, United States

View Trial Details

Completed

Prevention of Severe Anaemia in Gambian Children

NCT00131716

Conditions: Anemia, Disease Attributes, Hematologic Diseases, +13 more
Locations: Medical Research Council Laboratories, Banjul, The Gambia

View Trial Details

Completed

Phase 1 Study of BIIB022 (Anti-IGF-1R Monoclonal Antibody) in Relapsed/Refractory Solid Tumors

NCT00555724

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: Research Site Los Angeles, California, United States

Research Site Aurora, Colorado, United States

Research Site Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Laparoscopic Sentinel Node Navigation Surgery for Gastric Cancer

NCT01441310

Conditions: Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, +10 more
Locations: Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea

View Trial Details

Completed

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

NCT01989845

Conditions: Bleeding, Cancer-associated Thrombosis, Disease Attributes, +5 more
Locations: Seoul National University Bundang Hospital Seongnam, South Korea

View Trial Details

Completed

Diet Intervention, Head and Neck Cancer, Feasibility

NCT03013699

Conditions: Disease Attributes, Head and Neck Cancer, Head and Neck Neoplasms, +5 more
Locations: Not specified

View Trial Details

Completed

A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies

NCT00741403

Conditions: Advanced Cancer, Advanced Malignancies, Disease Attributes, +15 more
Locations: Pivotal Research Centers Peoria, Arizona, United States

Eastchester Center for Cancer Care The Bronx, New York, United States

Mary Crowley Cancer Research Centers Dallas, Texas, United States

British Columbia Cancer Agency Vancouver, British Columbia, Canada

View Trial Details

Completed

"LANK-2": Activated and Expanded NK Cell Immunotherapy Together With Salvage Chemotherapy in Children, Adolescents and Young Adults With Relapsed or Refractary Acute Leukemia

NCT02074657

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: Hospital 12 de Octubre Madrid, Spain

Hospital Infantil Universitario La Paz Madrid, Spain

View Trial Details

Completed

Retrospective Analysis on Relapsed/Refractory Aggressive Non Hodgkin Lymphoma Treated With Z-BEAM Plus ASCT

NCT02992223

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Markers of Response to Intravesical Bladder Cancer Therapy

NCT01007058

Conditions: Bladder Cancer, Disease Attributes, Female Urogenital Diseases, +13 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recurrence

Recurrence trial results

Related conditions